Colloidal Quantum Dot Biosensing via Luminescence Blinking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing QD-based biosensing methods rely on fluorescence changes induced by analyte-QD interactions, which are sensitive to donor-acceptor distances and difficult to modify for a wide range of analytes, limiting their versatility and sensitivity.

Innovation Solution

The use of colloidal quantum dots that exhibit luminescence blinking in a non-aggregated state and non-blinking in an aggregated state, allowing for detection of analytes through assembly or disassembly of luminescent species without relying on charge or energy transfer, with methods involving analyte binding species to facilitate aggregation or disassembly.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If QD-based biosensing relies on fluorescence changes induced by analyte-QD interactions, then the sensing mechanism is straightforward to detect, but it is difficult to design a QD-based system that can undergo such dramatic fluorescence changes

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddesign flexibility for different analytes
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent introduces an intermediary mechanism where analyte binding induces aggregation or disassembly of QD assemblies rather than relying on direct fluorescence changes from individual QD-analyte interactions. This mediator approach (aggregation state) enables versatile detection across different analytes while maintaining high sensitivity through the assembly-dependent luminescence signal changes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If QD-based sensing relies on charge transfer or energy transfer between QD fluorophore and microenvironment, then the sensing mechanism is well-established, but it requires radical redesign of the sensor for a given analyte

Engineering Contradiction:
Improvesensing mechanism stabilityVSAvoidsensor redesign requirements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent changes the detection parameter from fluorescence intensity/color (which requires microenvironment engineering) to luminescence blinking behavior. This parameter change enables a universal sensing mechanism where analyte detection is achieved through aggregation-induced blinking suppression, eliminating the need for analyte-specific sensor redesign while maintaining reliable detection.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If individual QD fluorescence changes are used for detection, then the signal is straightforward to detect, but the detection limits are higher

Engineering Contradiction:
Improvesignal detectabilityVSAvoiddetection limit
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent merges multiple QDs into assemblies where their collective luminescence behavior produces a non-blinking signal that is more readily detectable. By combining the emission from multiple QDs in an assembly, the system achieves both improved detectability and lower detection limits, as the aggregated signal provides a stronger, more stable readout compared to individual QD fluorescence.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables sensitive and versatile biosensing with lower detection limits and a long shelf-life, as it allows for the detection of analytes by correlating luminescence patterns without radical redesign of the sensor system, and can be applied to a variety of analytes.

Implementation Method 1

a population of luminescent species, wherein the luminescent species, in a non-aggregated state, exhibits luminescence blinking and, in an aggregated state, does not exhibit luminescence blinking

Methodology Applied
Scientific EffectLuminescence: Luminescence

Implementation Method 2

exposing the test sample to electromagnetic radiation having a wavelength corresponding to an excitation wavelength of the luminescent species, and detecting light emitted by the luminescent species

Methodology Applied
Scientific EffectPhotoluminescence: Photoluminescence

Data Source

PatentUS20200240992A1Methods and compositions for biosensing
Publication Date: 2020.07.30 THE UNIV OF NORTH CAROLINA AT CHAPEL HILL
  • US20200240992A1 patent drawing
  • US20200240992A1 patent drawing
  • US20200240992A1 patent drawing

AI summary

In one aspect, methods of sensing are described herein. In some embodiments, such a method comprises disposing a population of luminescent species in a test sample, exposing the test sample to electromagnetic radiation having a wavelength corresponding to an excitation wavelength of the luminescent species, detecting light emitted by the luminescent species within a detection region of the test sample, and correlating the light emitted by the luminescent species within the detection region to a presence or absence of an analyte within the test sample. The luminescent species, in a non-aggregated state, exhibits luminescence blinking and, in an aggregated state, does not exhibit luminescence blinking. Additionally, correlating the light emitted by the luminescent species to the presence or absence of the analyte comprises determining whether the light emitted by the luminescent species within the detection region is blinking luminescence or non-blinking luminescence.